Current Neuropharmacology

ISSN 1570-159X

Current Neuropharmacology aims to provide current, timely and comprehensive reviews of all areas of neuropharmacology and related matters of neuroscience. The journal publishes reviews written by experts and leaders in the fields of molecular, cellular, and systems/behavioural aspects of neuropharmacology and neuroscience. The journal serves as a comprehensive, multidisciplinary expert forum for neuropharmacologists and neuroscientists.

Publisher: Bentham Science Publishers

Volume 5, Number 2, June 2007

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Articles

The Cannabinoid CB2 Receptor as a Target for Inflammation-Dependent Neurodegeneration
pp. 73-80(8)
Authors: Ashton, John C.; Glass, Michelle

Neuropharmacology of the Endocannabinoid Signaling System-Molecular Mechanisms, Biological Actions and Synaptic Plasticity
pp. 81-97(17)
Author: Basavarajappa, Balapal S.

Parkinson's Disease: Genetics and Beyond
pp. 99-113(15)
Authors: Inamdar, N. N.; Arulmozhi, D. K.; Tandon, A.; Bodhankar, S. L.

Cell and Gene Therapies for Refractory Epilepsy
pp. 115-125(11)
Author: Boison, Detlev

Current Experimental Therapy for Alzheimer's Disease
pp. 127-134(8)
Authors: Chen, Sheng; Zhang, Xiao-Jie; Li, Liang; Le, Wei-Dong

The Neurobiological Bases for Development of Pharmacological Treatments of Aggressive Disorders
pp. 135-147(13)
Authors: Siegel, Allan; Bhatt, Suresh; Bhatt, Rekha; Zalcman, Steven S.

Key:

- Free Content

- New Content

- Subscribed Content

- Free Trial Content

Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.

Click here for Page Help

Advanced search

Search History

Tools

Print
Subscribe
- Activate Personal Subscription
Export
- Endnote
- BibT_EX
- RDF
Links
Alerting Options
Bookmark
- Marked List
- Social Bookmarking Links

Need to register?
Sign up here

Text size: A | A | A | A